These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 8895044

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study.
    Gris P.
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():93-101. PubMed ID: 8818850
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Open randomized study comparing doxycycline and co-amoxiclav in the treatment of acute suppurative tracheobronchitis in adults. The Collaborative Group of the Centre Universitaire de Medécine Générale de L'Université Libre de Bruxelles (CUMG-ULB) Investigators.
    Sternon J.
    J Int Med Res; 1995 Jun; 23(5):369-76. PubMed ID: 8529780
    [Abstract] [Full Text] [Related]

  • 5. A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections.
    Zachariah J.
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():103-13. PubMed ID: 8818851
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A multicenter, open label trial of azithromycin vs. amoxicillin/ clavulanate for the management of acute otitis media in children.
    Aronovitz G.
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S15-9. PubMed ID: 8878241
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media.
    Dunne MW, Latiolais T, Lewis B, Pistorius B, Bottenfield G, Moore WH, Garrett A, Stewart TD, Aoki J, Spiegel C, Boettger D, Shemer A.
    J Antimicrob Chemother; 2003 Sep; 52(3):469-72. PubMed ID: 12888586
    [Abstract] [Full Text] [Related]

  • 10. Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections.
    Ferwerda A, Moll HA, Hop WC, Kouwenberg JM, Tjon Pian Gi CV, Robben SG, de Groot R.
    J Antimicrob Chemother; 2001 Apr; 47(4):441-6. PubMed ID: 11266417
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis.
    Beghi G, Berni F, Carratù L, Casalini A, Consigli G, D'Antò M, Gioia V, Molino A, Paizis G, Vaghi A.
    J Chemother; 1995 Apr; 7(2):146-52. PubMed ID: 7666122
    [Abstract] [Full Text] [Related]

  • 12. Dirithromycin versus amoxiclav in the treatment of acute exacerbations of chronic bronchitis.
    Van Royen P, Betz W, Heyrman J, Taziaux P, Van den Haute M, Poelman M.
    J Int Med Res; 1997 Apr; 25(1):33-40. PubMed ID: 9027671
    [Abstract] [Full Text] [Related]

  • 13. A comparison of the efficacy, tolerability and safety of azithromycin and co-amoxiclav in the treatment of sinusitis in adults.
    Clement PA, de Gandt JB.
    J Int Med Res; 1998 Apr; 26(2):66-75. PubMed ID: 9602984
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the efficacy, safety and tolerability of azithromycin and co-amoxiclav in the treatment of acute periapical abscesses.
    Adriaenssen CF.
    J Int Med Res; 1998 Apr; 26(5):257-65. PubMed ID: 9924711
    [Abstract] [Full Text] [Related]

  • 15. Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
    Cazzola M, Vinciguerra A, Beghi GF, Paizis G, Giura R, Madonini V, Fiorentini F, Consigli GF, Tonna M, Casalini A.
    J Chemother; 1995 Oct; 7(5):432-41. PubMed ID: 8596127
    [Abstract] [Full Text] [Related]

  • 16. A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections.
    Hoepelman AI, Sips AP, van Helmond JL, van Barneveld PW, Neve AJ, Zwinkels M, Rozenberg-Arska M, Verhoef J.
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():147-52. PubMed ID: 8396086
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitis.
    De Abate CA, Perrotta RJ, Dennington ML, Ziering RM.
    J Chemother; 1992 Dec; 4(6):358-63. PubMed ID: 1287138
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
    Starakis I, Gogos CA, Bassaris H.
    Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.